Elucidating the Molecular and Biochemical Basis of the Human AhR-mutation Disease

Mutation, Point Clinical Trial

Official title: Elucidating the Molecular and Biochemical Basis of the Human AhR-mutation Disease

Status Not yet recruiting

Clinical Trial Summary

In a previous study, we have identified a consanguineous family from Northern Israel with three children affected by idiopathic infantile nystagmus (IIN) and foveal hypoplasia, which follow an autosomal recessive mode of inheritance of AhR gene. in this study we will determine whether the disease phenotype is the consequence of a decrease in or absence of AHR-induced AHH activity

Clinical Trial Description

In a previous study, we have identified a consanguineous family from Northern Israel with three children affected by idiopathic infantile nystagmus (IIN) and foveal hypoplasia, which follow an autosomal recessive mode of inheritance of AhR gene. in this study we will:

1. To determine whether the disease phenotype is the consequence of a decrease in or absence of AHR-induced AHH activity. To this end, basal and ligand-mediated AHH enzyme activity will be compared in heterozygotic and homozygotic family members versus healthy volunteers.

2. To examine steady state protein levels of the AHR protein in cells of homo- and heterozygotic patients versus those of healthy volunteers. If no mutant protein is detected, we will determine the effect of the mutation on mRNA stability.

3. To analyze steady state levels of related partner proteins (such as ANRT) and proteins levels of transcriptional targets (AHH) in heterozygotic and homozygotic family members versus healthy volunteers.

4. To investigate the ability of the mutant allele to induce transcriptional activation in an engineered yeast test system. We will use a yeast strain engineered to contain human AHR and AHR nuclear translocator together with a reporter gene to investigate whether the mutation interferes with transcription activation. ;

Related Conditions & MeSH terms

• Mutation, Point

• NCT number: NCT03566745
• Study type: Observational
• Source: Hillel Yaffe Medical Center
• Contact: Muhammad Mahajnah, MD PhD
• Phone: +972506246959
• Email: mohamedm@hy.health.gov.il
• Status: Not yet recruiting
• Start date: July 1, 2018
• Completion date: November 30, 2019